Drug intelligence / Profile preview

dopamine + dextrose

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous
01

Overview

Dopamine + dextrose is a sterile premixed intravenous solution containing dopamine hydrochloride (a catecholamine inotropic/vasopressor agent) dissolved in 5% dextrose as a stabilizing vehicle and calorie source. Dopamine acts primarily as a sympathomimetic amine with dose-dependent agonist activity on dopamine (D1, D2), beta-1, and at higher doses, alpha-1 adrenergic receptors. It increases cardiac contractility and output (inotropy), improves renal and mesenteric blood flow, and at higher doses causes vasoconstriction to treat hypotension. The addition of dextrose provides calories and prevents hypoglycemia. The main clinical uses are for the correction of hemodynamic imbalances seen in shock (due to myocardial infarction, trauma, sepsis, open-heart surgery, renal failure), low cardiac output, and as adjunct in congestive heart failure or post-operative states requiring inotropic support[1][2][4][8][10][11].

Brand names
Dopamine Hydrochloride and 5% Dextrose InjectionDopamine HCl in 5% Dextrose
Other names
dopamine hydrochloride and 5% dextrosedopamine/dextrose premix
02

Targets

ADRA1A (α1A)DRD1 (Dopamine D1 Receptor)DRD2 (Dopamine D2 Receptor)ADRB1 (β1)

Beyond the preview

Go deeper on dopamine + dextrose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dopamine + dextrose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call